施乐辉

Smith & Nephew cuts outlook on China weakness

FTSE 100 medical manufacturer reports price pressures and worse-than-expected demand
Sales in China were affected by that country’s programme to award large contracts to companies that submit low-cost bids

Smith & Nephew cut its annual forecast on Thursday as it warned of unexpectedly weak demand for medical equipment in China, sending shares down 12 per cent.

The FTSE 100 group, which makes a range of medical supplies including hip and knee replacements, said it was hit by “worse than expected headwinds” in China in the third quarter, which it expected to continue into 2025.

您已阅读19%(497字),剩余81%(2082字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×